Collplant Biotechnologies Ltd

CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. It operates in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant human collagen (rhCollagen) produced with its proprietary technology. The company offers regenerative dermal and soft tissue fillers, 3D-bioprinted regenerative breast implants, Collage (a recombinant human Collagen type I solution), VergenixSTR (a soft tissue matrix for tendinopathy), and VergenixFG (a wound care product for deep surgical incisions and deep wounds). It also provides rhCollagen-based commercial bioinks for regenerative medicine, including Collink.3D 50L (powder form), Collink.3D 90 (solution), and Collink.3D 50. The company has collaboration agreements with AbbVie, STEMCELL, the Advanced Regenerative Manufacturing Institute, Stratasys, and RegenMed Development Organization. Formerly known as CollPlant Holdings Ltd., it changed its name to CollPlant Biotechnologies Ltd. in June 2019. Founded in 2004, it is headquartered in Rehovot, Israel.